Joel Greenblatt’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-3,633
| Closed | -$200K | – | 1176 |
|
|
2021
Q4 | $200K | Buy |
+3,633
| New | +$189K | 0.01% | 1082 |
|
|
2021
Q3 | – | Sell |
-6,839
| Closed | -$340K | – | 1061 |
|
|
2021
Q2 | $340K | Hold |
6,839
| – | – | 0.01% | 799 |
|
|
2021
Q1 | $305K | Buy |
+6,839
| New | +$310K | 0.01% | 835 |
|
|
2020
Q1 | – | Sell |
-6,729
| Closed | -$395K | – | 1122 |
|
|
2019
Q4 | $395K | Hold |
6,729
| – | – | 0.01% | 873 |
|
|
2019
Q3 | $359K | Buy |
6,729
+25
| +0.4% | +$1.29K | 0.01% | 860 |
|
|
2019
Q2 | $335K | Hold |
6,704
| – | – | 0.01% | 920 |
|
|
2019
Q1 | $350K | Buy |
6,704
+28
| +0.4% | +$1.4K | 0.01% | 957 |
|
|
2018
Q4 | $319K | Buy |
6,676
+58
| +0.9% | +$2.86K | 0.01% | 854 |
|
|
2018
Q3 | $332K | Hold |
6,618
| – | – | ﹤0.01% | 818 |
|
|
2018
Q2 | $333K | Sell |
6,618
-15,715
| -70% | -$791K | ﹤0.01% | 762 |
|
|
2018
Q1 | $1.09M | Sell |
22,333
-1
| -0% | -$47 | 0.02% | 600 |
|
|
2017
Q4 | $990K | Buy |
22,334
+580
| +3% | +$26.8K | 0.01% | 592 |
|
|
2017
Q3 | $1.1M | Buy |
21,754
+558
| +3% | +$28.3K | 0.02% | 596 |
|
|
2017
Q2 | $1.14M | Buy |
21,196
+882
| +4% | +$47K | 0.02% | 620 |
|
|
2017
Q1 | $1.07M | Sell |
20,314
-738
| -4% | -$37.4K | 0.01% | 655 |
|
|
2016
Q4 | $1.01M | Buy |
21,052
+825
| +4% | +$40.8K | 0.01% | 619 |
|
|
2016
Q3 | $1.09M | Sell |
20,227
-459
| -2% | -$25.2K | 0.01% | 591 |
|
|
2016
Q2 | $1.12M | Sell |
20,686
-20,379
| -50% | -$1.07M | 0.01% | 615 |
|
|
2016
Q1 | $2.08M | Sell |
41,065
-513
| -1% | -$25.6K | 0.02% | 568 |
|
|
2015
Q4 | $2.1M | Buy |
41,578
+417
| +1% | +$21.3K | 0.02% | 518 |
|
|
2015
Q3 | $1.98M | Sell |
41,161
-22,965
| -36% | -$1.2M | 0.02% | 542 |
|
|
2015
Q2 | $3.34M | Sell |
64,126
-2,736
| -4% | -$154K | 0.03% | 498 |
|
|
2015
Q1 | $3.86M | Buy |
66,862
+276
| +0.4% | +$15.8K | 0.03% | 458 |
|
|
2014
Q4 | $3.56M | Sell |
66,586
-184
| -0.3% | -$10.3K | 0.03% | 461 |
|
|
2014
Q3 | $3.84M | Sell |
66,770
-52
| -0.1% | -$3.19K | 0.04% | 449 |
|
|
2014
Q2 | $4.47M | Buy |
66,822
+60
| +0.1% | +$4.06K | 0.06% | 421 |
|
|
2014
Q1 | $4.46M | Hold |
66,762
| – | – | 0.07% | 380 |
|
|
2013
Q4 | $4.46M | Buy |
+66,762
| New | +$4.33M | 0.11% | 306 |
|
Other funds holding GSK
BCIM
JEST
Joel Greenblatt's GSK Position: Q1 2022 in Review
Joel Greenblatt sold out of GSK (GSK) in Q1 2022, closing a stake of 3,633 shares — an estimated $200K sold.
Joel Greenblatt first reported a position in GSK in Q4 2013 and held it in 28 quarters. The position peaked at $4.47M in Q2 2014. 930 funds tracked by Wall St. Rank hold GSK as of Q1 2022.
- Joel Greenblatt reported no remaining GSK position as of Q1 2022 after selling out during the quarter.
- Joel Greenblatt sold 3,633 GSK shares in Q1 2022, an estimated $200K.
- Joel Greenblatt first reported a position in GSK in Q4 2013 and held it in 28 quarters.
- Joel Greenblatt's GSK position peaked at $4.47M in Q2 2014.
- 930 funds tracked by Wall St. Rank held GSK as of Q1 2022.
Based on Gotham Asset Management's 13F filing for Q1 2022, filed 16 May 2022.